B. Braun New Ventures is a Corporate Start-Up of B. Braun based in Freiburg, Germany, founded in 2020. With a young and fast-growing team, we are set up to support B. Braun’s digital transformation by developing solutions to automate medical procedures across all business areas. The goal is to augment caregivers’ eyes, hands and decision making with sensors, robotics and artificial intelligence. This will enable sharing of clinical experience, open up new treatment possibilities and result in better patient care.

More information

B. Braun New Ventures is a Corporate Start-Up of B. Braun based in Freiburg, Germany, founded in 2020. With a young and fast-growing team, we are set up to support B. Braun’s digital transformation by developing solutions to automate medical procedures across all business areas. The goal is to augment caregivers’ eyes, hands and decision making with sensors, robotics and artificial intelligence. This will enable sharing of clinical experience, open up new treatment possibilities and result in better patient care.

More information

The CURAC Academy is a novel way to network and learn. For more information, please visit: https://curac.org/de/curac-gesellschaft/curac-academy

The Austrian Science Fund (https://FWF.ac.at) has awarded a highly competitive internationally peer-reviewed graduate doctoral program "doc.funds" to the Medical University Innsbruck.

All pertinent details are available at https://phd-igdt-art.i-med.ac.at.

We proudly announce the opening of 15 fully funded PhD positions (four
years) within this program of excellency and invite all interested persons to express their interest in such a position.

Applications will be ranked for excellency and PhD positions will be awarded after a hearing to start as early as October 2021.

We would be pleased to hear from you and invite you to join Medical University Innsbruck, the medical science hub in the Alps.

Wolfgang Freysinger
member of the PhD-IGDT-ART consortium
CURAC founding member